NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,791,237 | -18.3% | 9,111,151 | 0.0% | 0.96% | -6.0% |
| Q2 2023 | $35,260,154 | +39.7% | 9,111,151 | 0.0% | 1.02% | +37.0% |
| Q1 2023 | $25,237,888 | +53.9% | 9,111,151 | 0.0% | 0.74% | +61.6% |
| Q4 2022 | $16,400,071 | -15.1% | 9,111,151 | 0.0% | 0.46% | -17.8% |
| Q3 2022 | $19,315,000 | -21.2% | 9,111,151 | 0.0% | 0.56% | -27.0% |
| Q2 2022 | $24,508,000 | -38.0% | 9,111,151 | 0.0% | 0.77% | -3.0% |
| Q1 2022 | $39,542,000 | -58.1% | 9,111,151 | -50.0% | 0.79% | +8.8% |
| Q4 2021 | $94,390,000 | +72.5% | 18,222,302 | +104.5% | 0.73% | -8.4% |
| Q3 2021 | $54,714,000 | -69.6% | 8,911,151 | -50.0% | 0.80% | -32.0% |
| Q2 2021 | $180,004,000 | – | 17,822,302 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |